11:33 IST
BSE
Annual Report
Marksans Pharma Annual Report
Marksans Pharma Ltd submitted its Annual Report for FY 2025-26. The filing also includes a notice for the 34th Annual General Meeting.
Marksans Pharma Ltd
- Share price
- ₹325.45
- Market cap
- ₹14,748 Cr
- Revenue (annual)
- ₹2,951 Cr
- Net profit (annual)
- ₹417.9 Cr
- P/E (TTM)
- 28.5×Sector 47.3×
- Promoter holding
- 43.87%+0.00% QoQ
- FII holding
- 17.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Other Announcement 4Financial Results 3Acquisition 3Merger & Restructuring 2Board Meeting Date 2Annual General Meeting 2Results Update 1Promoter Selling (Off-Market) 1Employee Stock Options 1Dividend 1Credit Rating 1Business Update 1Board Meeting Outcome 1Annual Report 1
Time
1 announcement with these filters